Skip to the edition
Sharespective Wall Street, before morning tea
Daily newsletter
Sat 10 Oct 2026
Health care From the edition of Saturday 10 October 2026

Humana's Medicare plans won back their stars, and the shares jumped 11.56%

Humana

Humana rose 11.56% to US$431.87 on Friday. It opened at US$450.49 and was up almost 18% at its high before giving some of that back.

The stars are a government scorecard. Medicare Advantage plans are private health plans that cover Americans aged 65 and over in place of the government's own Medicare. Washington rates them from one to five stars every year, and plans with four or more earn bonus payments worth billions.

The ratings for 2027 are now out. Humana said 95% of its Medicare Advantage members are in plans rated four stars or higher, up from 20% this year. JPMorgan's analysts had expected between 60% and 70%.

Chart: Humana won back its stars, and its value climbed. Humana's market value at each year end since 2021 and on 9 October 2026, in US$bn. The shares rose 11.56% that day after the 2027 star ratings came out.
This story’s chart of the day.

Its rivals did worse. Across the industry about 71% of members will be in four-star plans, Reuters reported, and UnitedHealth is expected to fall to about 67% from 81%. CVS Health lost 1.87%.

Evercore ISI's Elizabeth Anderson said the jump shows how much weight Humana's management put on fixing the ratings over the past year.

The catch

the bonus money tied to these ratings is paid in 2028. The plans are scored again next October, so the bonus for 2029 is still to be won.

This story ran in Bad Reception Saturday 10 October’s edition, with the market snapshot, the other two stories, the numbers and the week ahead. Read the whole edition →

More in

All stories →

General information and commentary only, not financial advice. It does not take account of your objectives, financial situation or needs, and reflects the author's own reading of public information at the time of writing, which may be wrong. Sharespective, its people and its clients may hold positions in the companies covered. Do your own research and talk to a licensed adviser.

Still reading? Then tomorrow's edition is probably for you.

Free, six mornings a week, Monday to Saturday

You're in. Check your inbox to confirm.

That address didn't go through. Check it and try again.